Barclays analyst Lauren Lieberman maintained a Sell rating on Clorox (CLX – Research Report) on January 12 and set a price target of $110.00. The company’s shares closed yesterday at $146.11.
Lieberman covers the Consumer Goods sector, focusing on stocks such as Constellation Brands, International Flavors & Fragrances, and Church & Dwight. According to TipRanks, Lieberman has an average return of 2.4% and a 54.29% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Clorox with a $135.80 average price target, implying a -7.06% downside from current levels. In a report released yesterday, J.P. Morgan also maintained a Sell rating on the stock with a $135.00 price target.
See today’s best-performing stocks on TipRanks >>
Based on Clorox’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.74 billion and a net profit of $85 million. In comparison, last year the company earned a revenue of $1.81 billion and had a net profit of $142 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1913, California-based The Clorox Co. manufactures and markets consumer and professional products. It operates through four business segments: Health and Wellness, Household, Lifestyle, and International.
Read More on CLX:
